JAGX

Jaguar Health, Inc.

Insider trading activity for Jaguar Health, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 43 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Dec 11, 2025	Siegel Jonathan B.	Director	AGRANT◆	7,377	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Siegel Jonathan B.	Director	AGRANT	7,377	—	—	+16,037%	Open the original filing on SEC.gov
Dec 11, 2025	Jayasuriya Anula	Director	AGRANT◆	5,870	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Jayasuriya Anula	Director	AGRANT	5,870	—	—	+12,761%	Open the original filing on SEC.gov
Dec 11, 2025	Lizak Carol R.	Chief Financial Officer	AGRANT◆	11,740	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Lizak Carol R.	Chief Financial Officer	AGRANT	11,740	—	—	+6,866%	Open the original filing on SEC.gov
Dec 11, 2025	Chaturvedi Pravin R	Chief Scientific Officer	AGRANT◆	11,740	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Chaturvedi Pravin R	Chief Scientific Officer	AGRANT	11,740	—	—	+5,929%	Open the original filing on SEC.gov
Dec 11, 2025	Bochnowski James J	Director	AGRANT◆	6,363	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Bochnowski James J	Director	AGRANT	6,363	—	—	+12,237%	Open the original filing on SEC.gov
Dec 11, 2025	King Steven R.	See Remarks	AGRANT◆	11,740	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	King Steven R.	See Remarks	AGRANT	11,740	—	—	+8,097%	Open the original filing on SEC.gov
Dec 11, 2025	Wolin Jonathan S.	See Remarks	AGRANT◆	11,740	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Wolin Jonathan S.	See Remarks	AGRANT	11,740	—	—	+5,929%	Open the original filing on SEC.gov
Dec 11, 2025	Conte Lisa A	See Remarks	AGRANT◆	28,592	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Conte Lisa A	See Remarks	AGRANT	28,592	—	—	+4,293%	Open the original filing on SEC.gov
Dec 11, 2025	Micek John	Director	AGRANT◆	7,377	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Micek John	Director	AGRANT	7,377	—	—	+13,919%	Open the original filing on SEC.gov
Jun 24, 2025	Siegel Jonathan B.	Director	AGRANT◆	18,262	—	—	—	Open the original filing on SEC.gov
Jun 24, 2025	Siegel Jonathan B.	Director	AGRANT◆	9,462	$50,000.00	$473.1M	—	Open the original filing on SEC.gov
Jun 24, 2025	Siegel Jonathan B.	Director	DTOISS◆	9,000	$50,000.00	$450M	—	Open the original filing on SEC.gov
Jun 24, 2025	Micek John	Director	AGRANT◆	18,262	—	—	—	Open the original filing on SEC.gov
Jun 24, 2025	Micek John	Director	AGRANT◆	9,462	$50,000.00	$473.1M	—	Open the original filing on SEC.gov
Jun 24, 2025	Micek John	Director	DTOISS◆	9,000	$50,000.00	$450M	—	Open the original filing on SEC.gov
Jun 24, 2025	King Steven R.	See Remarks	AGRANT◆	7,304	—	—	—	Open the original filing on SEC.gov
Jun 24, 2025	King Steven R.	See Remarks	AGRANT◆	3,785	$20.00	$75.7K	—	Open the original filing on SEC.gov
Jun 24, 2025	King Steven R.	See Remarks	DTOISS◆	3,600	$20,000.00	$72M	—	Open the original filing on SEC.gov
Jun 24, 2025	Wolin Jonathan S.	See Remarks	AGRANT◆	18,262	—	—	—	Open the original filing on SEC.gov
Jun 24, 2025	Wolin Jonathan S.	See Remarks	AGRANT◆	9,462	$50,000.00	$473.1M	—	Open the original filing on SEC.gov
Jun 24, 2025	Wolin Jonathan S.	See Remarks	DTOISS◆	9,000	$50,000.00	$450M	—	Open the original filing on SEC.gov
Jun 24, 2025	Chaturvedi Pravin R	Chief Scientific Officer	AGRANT◆	7,304	—	—	—	Open the original filing on SEC.gov
Jun 24, 2025	Chaturvedi Pravin R	Chief Scientific Officer	AGRANT◆	3,785	$20,000.00	$75.7M	—	Open the original filing on SEC.gov
Jun 24, 2025	Chaturvedi Pravin R	Chief Scientific Officer	DTOISS◆	3,600	$20,000.00	$72M	—	Open the original filing on SEC.gov
Jun 24, 2025	Conte Lisa A	CEO and President	AGRANT◆	18,262	—	—	—	Open the original filing on SEC.gov
Jun 24, 2025	Conte Lisa A	CEO and President	AGRANT◆	9,462	$50,000.00	$473.1M	—	Open the original filing on SEC.gov
Jun 24, 2025	Conte Lisa A	CEO and President	DTOISS◆	9,000	$50,000.00	$450M	—	Open the original filing on SEC.gov
Jun 24, 2025	Bochnowski James J	Director	AGRANT◆	54,786	—	—	—	Open the original filing on SEC.gov
Jun 24, 2025	Bochnowski James J	Director	AGRANT◆	28,388	$150,000.00	$4.3B	—	Open the original filing on SEC.gov
Jun 24, 2025	Bochnowski James J	Director	DTOISS◆	27,002	$150,000.00	$4.1B	—	Open the original filing on SEC.gov
May 17, 2025	King Steven R.	See Remarks	MEXER◆	1	—	—	—	Open the original filing on SEC.gov
May 17, 2025	King Steven R.	See Remarks	MEXER	1	—	—	+0.7%	Open the original filing on SEC.gov
May 17, 2025	Conte Lisa A	CEO and President	MEXER◆	2	—	—	—	Open the original filing on SEC.gov
May 17, 2025	Conte Lisa A	CEO and President	MEXER	2	—	—	+0.3%	Open the original filing on SEC.gov

AGRANT◆—

Siegel Jonathan B. · DirectorDec 11, 2025

7,377 sh

AGRANT—

Siegel Jonathan B. · DirectorDec 11, 2025

7,377 sh · +16,037% own

AGRANT◆—

Jayasuriya Anula · DirectorDec 11, 2025

5,870 sh

AGRANT—

Jayasuriya Anula · DirectorDec 11, 2025

5,870 sh · +12,761% own

AGRANT◆—

Lizak Carol R. · Chief Financial…Dec 11, 2025

11,740 sh

AGRANT—

Lizak Carol R. · Chief Financial…Dec 11, 2025

11,740 sh · +6,866% own

AGRANT◆—

Chaturvedi Pravin R · Chief Scientific…Dec 11, 2025

11,740 sh

AGRANT—

Chaturvedi Pravin R · Chief Scientific…Dec 11, 2025

11,740 sh · +5,929% own

AGRANT◆—

Bochnowski James J · DirectorDec 11, 2025

6,363 sh

AGRANT—

Bochnowski James J · DirectorDec 11, 2025

6,363 sh · +12,237% own

AGRANT◆—

King Steven R. · See RemarksDec 11, 2025

11,740 sh

AGRANT—

King Steven R. · See RemarksDec 11, 2025

11,740 sh · +8,097% own

AGRANT◆—

Wolin Jonathan S. · See RemarksDec 11, 2025

11,740 sh

AGRANT—

Wolin Jonathan S. · See RemarksDec 11, 2025

11,740 sh · +5,929% own

AGRANT◆—

Conte Lisa A · See RemarksDec 11, 2025

28,592 sh

AGRANT—

Conte Lisa A · See RemarksDec 11, 2025

28,592 sh · +4,293% own

AGRANT◆—

Micek John · DirectorDec 11, 2025

7,377 sh

AGRANT—

Micek John · DirectorDec 11, 2025

7,377 sh · +13,919% own

AGRANT◆—

Siegel Jonathan B. · DirectorJun 24, 2025

18,262 sh

AGRANT◆$473.1M

Siegel Jonathan B. · DirectorJun 24, 2025

9,462 sh @ $50,000.00

DTOISS◆$450M

Siegel Jonathan B. · DirectorJun 24, 2025

9,000 sh @ $50,000.00

AGRANT◆—

Micek John · DirectorJun 24, 2025

18,262 sh

AGRANT◆$473.1M

Micek John · DirectorJun 24, 2025

9,462 sh @ $50,000.00

DTOISS◆$450M

Micek John · DirectorJun 24, 2025

9,000 sh @ $50,000.00

AGRANT◆—

King Steven R. · See RemarksJun 24, 2025

7,304 sh

AGRANT◆$75.7K

King Steven R. · See RemarksJun 24, 2025

3,785 sh @ $20.00

DTOISS◆$72M

King Steven R. · See RemarksJun 24, 2025

3,600 sh @ $20,000.00

AGRANT◆—

Wolin Jonathan S. · See RemarksJun 24, 2025

18,262 sh

AGRANT◆$473.1M

Wolin Jonathan S. · See RemarksJun 24, 2025

9,462 sh @ $50,000.00

DTOISS◆$450M

Wolin Jonathan S. · See RemarksJun 24, 2025

9,000 sh @ $50,000.00

AGRANT◆—

Chaturvedi Pravin R · Chief Scientific…Jun 24, 2025

7,304 sh

AGRANT◆$75.7M

Chaturvedi Pravin R · Chief Scientific…Jun 24, 2025

3,785 sh @ $20,000.00

DTOISS◆$72M

Chaturvedi Pravin R · Chief Scientific…Jun 24, 2025

3,600 sh @ $20,000.00

AGRANT◆—

Conte Lisa A · CEO and PresidentJun 24, 2025

18,262 sh

AGRANT◆$473.1M

Conte Lisa A · CEO and PresidentJun 24, 2025

9,462 sh @ $50,000.00

DTOISS◆$450M

Conte Lisa A · CEO and PresidentJun 24, 2025

9,000 sh @ $50,000.00

AGRANT◆—

Bochnowski James J · DirectorJun 24, 2025

54,786 sh

AGRANT◆$4.3B

Bochnowski James J · DirectorJun 24, 2025

28,388 sh @ $150,000.00

DTOISS◆$4.1B

Bochnowski James J · DirectorJun 24, 2025

27,002 sh @ $150,000.00

MEXER◆—

King Steven R. · See RemarksMay 17, 2025

1 sh

MEXER—

King Steven R. · See RemarksMay 17, 2025

1 sh · +0.7% own

MEXER◆—

Conte Lisa A · CEO and PresidentMay 17, 2025

2 sh

MEXER—

Conte Lisa A · CEO and PresidentMay 17, 2025

2 sh · +0.3% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

4 of 18 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 58 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Dec 11, 2025	Mar 11	Micek JohnDirector	58days · about 3 months	—	Filing ↗
Dec 11, 2025	Jan 20	King Steven R.See Remarks	23days	—	Filing ↗
Dec 11, 2025	Jan 20	Conte Lisa ASee Remarks	23days	—	Filing ↗
Dec 11, 2025	Jan 20	Wolin Jonathan S.See Remarks	23days	—	Filing ↗

Micek JohnDirector

58days · about 3 months

Traded Dec 11, 2025 · filed Mar 11Filing ↗

King Steven R.See Remarks

23days

Traded Dec 11, 2025 · filed Jan 20Filing ↗

Conte Lisa ASee Remarks

23days

Traded Dec 11, 2025 · filed Jan 20Filing ↗

Wolin Jonathan S.See Remarks

23days

Traded Dec 11, 2025 · filed Jan 20Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →